Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.25 AUD | +2.17% | +5.19% | -18.90% |
Apr. 24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.90% | 1.68B | |
+33.40% | 690B | |
+26.43% | 546B | |
-5.05% | 358B | |
+18.80% | 323B | |
+4.58% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+3.93% | 161B |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- Transcript : Neuren Pharmaceuticals Limited, Q4 2023 Earnings Call, Feb 29, 2024